11 Treatment Options for Genitourinary Syndrome of Menopause Beyond Vaginal Estrogen That Women Are Never Told About
The thing that stings most about GSM is how many women suffer in silence because they assume dryness and pain during sex is just 'part of aging' and not worth mentioning to a doctor. When they do mention it, they're often handed a prescription and sent on their way — no discussion of the five other options that might suit them better. You deserve the whole picture, not just the first thing on the prescription pad.
Learn more about Rose →Vaginal DHEA (Prasterone / Intrarosa)
Vaginal DHEA, sold under the name prasterone, is a suppository inserted nightly that the vaginal cells themselves convert into both estrogen and testosterone locally. Because the conversion happens inside the tissue rather than entering the bloodstream in meaningful amounts, it's considered a low-systemic-absorption option — a genuine distinction for women who have concerns about estrogen. Clinical trials showed significant improvements in vaginal dryness, painful intercourse, and vaginal cell maturation compared to placebo.
Ospemifene (Osphena) — An Oral Non-Hormonal Pill
Ospemifene is a selective estrogen receptor modulator (SERM) taken as a daily oral tablet — the only non-hormonal, non-topical prescription option approved specifically for moderate to severe GSM symptoms including dyspareunia (painful sex). It acts like estrogen in vaginal tissue but not in the uterus, making it distinct from systemic hormone therapy. It's particularly relevant for women who cannot or prefer not to use anything inserted vaginally, though it does carry a small increase in hot flash frequency as a side effect.
Pelvic Floor Physical Therapy
A trained pelvic floor physiotherapist can address the muscular component of GSM that no cream or pill touches — specifically the hypertonicity (chronic tightening) that develops when the vaginal walls become fragile and penetration becomes painful. Over time, many women unconsciously brace against anticipated pain, creating a muscular tension cycle that persists even after the tissue has been treated. Multiple studies support pelvic PT for improving sexual function, reducing pain, and addressing the urinary symptoms — urgency, leaking, and frequency — that are also part of GSM.
Long-Acting Vaginal Moisturizers (Polycarbophil and Hyaluronic Acid)
Over-the-counter vaginal moisturizers — distinct from lubricants — are applied regularly (every two to three days) to maintain baseline vaginal hydration rather than just easing friction in the moment. Products based on polycarbophil have the longest evidence base, with studies showing measurable improvement in vaginal pH and symptom scores comparable to low-dose estrogen in some trials. Hyaluronic acid formulations are newer with emerging positive data and are particularly well-tolerated for women with sensitivities.
CO2 Fractional Laser Therapy (MonaLisa Touch and Equivalents)
Fractional CO2 laser devices deliver controlled micro-injuries to vaginal tissue, triggering a collagen remodeling response that thickens and re-hydrates the vaginal walls over a series of three to five sessions. The evidence is genuinely mixed — early enthusiasm has been tempered by more rigorous trials showing results that, while real, are more modest than initially marketed. The FDA has raised concerns about aggressive marketing claims, but the procedure remains a legitimate option being studied for women who cannot use hormonal therapies, particularly cancer survivors.
Erbium YAG Laser Therapy
The erbium YAG laser is a separate technology from CO2 laser, operating at a different wavelength with a shallower tissue effect and a reputation for a gentler recovery experience. Small RCTs and observational studies show improvements in vaginal dryness, pH normalization, and pain scores after a course of treatments. Research is less voluminous than for CO2 laser but is growing, and it remains a clinically used option in women's health practices that offer energy-based therapies.
Radiofrequency Devices (ThermiVa and Similar)
Non-ablative radiofrequency devices use thermal energy rather than laser to stimulate collagen production in vaginal and vulvar tissue without breaking the surface. They are typically marketed as requiring no downtime and are delivered in a series of sessions, with some women reporting improvement in both GSM symptoms and mild stress urinary incontinence. Evidence quality is lower than for laser therapies — most studies are small and lack robust controls — but it is a real and actively researched modality rather than a purely cosmetic one.
Topical Lidocaine Before Intercourse
A 4% aqueous lidocaine solution applied to the vestibule (the vaginal opening) for three minutes before intercourse has been studied as a practical pain-reduction strategy for women experiencing provoked vestibulodynia, a specific type of entry pain common in GSM. A small but well-designed RCT found it significantly reduced pain scores and improved sexual function compared to placebo. It is not a treatment for the underlying tissue change but offers immediate, real functional relief while other therapies take effect.
Testosterone (Off-Label Topical Use)
Testosterone receptors exist throughout the vulvovaginal tissue, and declining androgens in menopause contribute to tissue thinning and reduced sensation independently of estrogen loss. Low-dose topical testosterone applied to the vulva is used off-label by some clinicians for GSM, particularly for women reporting reduced genital sensitivity and difficulty with arousal. Formal regulatory approval for this indication does not currently exist in most countries, but the physiological rationale is sound and clinical use is growing, particularly in integrative and sexual medicine practices.
Sustained Sexual Activity and Regular Arousal
Regular sexual activity — including solo arousal — promotes vaginal blood flow, maintains tissue elasticity, and supports natural lubrication through a genuine use-it-or-lose-it physiological mechanism. Research confirms that sexually active postmenopausal women show measurably better vaginal health markers than those who are not, independent of hormone use. This is not a moral prescription but a physiological one: arousal drives engorgement, and engorgement is one of the mechanisms that maintains tissue health when estrogen is no longer doing that job.
Compounded Vaginal Estriol
Estriol is the weakest of the three human estrogens and is the form most predominantly produced during pregnancy; it has a long history of use in European gynecology for GSM but is not FDA-approved as a standalone product in the United States. Available through compounding pharmacies, vaginal estriol cream or suppositories are used by some clinicians as an alternative to estradiol-based products, particularly for women seeking a lower-potency option. Evidence for efficacy is strong in European literature, though the compounded nature means product consistency varies and women should use a reputable compounding pharmacy overseen by their prescribing clinician.
Want to go deeper?
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.